ClinicalTrials.Veeva

Menu
S

St. Joseph's Health Care London | Ivey Eye Institute

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
LX211
VX-121
APL-2
Faricimab
Pegcetacoplan
Bevasiranib
GSK3326595
Simufilam
Bimatoprost

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 48 total trials

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in pa...

Active, not recruiting
Cystic Fibrosis
Drug: VX-121/TEZ/D-IVA

The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-...

Enrolling
Geographic Atrophy
Drug: ANX007
Other: Sham Administration

This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.

Active, not recruiting
Uveitic Macular Edema
Other: Sham
Drug: Vamikibart

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)

Trial sponsors

L
Roche logo
W
A
L
Vertex Pharmaceuticals logo
O
Allergan logo
A
Astellas logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems